Cadence Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $6.51M | Sell |
261,420
-27,740
| -10% | -$700K | 0.38% | 58 |
|
|
2025
Q3 | $7.37M | Sell |
289,160
-643
| -0.2% | -$15.9K | 0.45% | 50 |
|
|
2025
Q2 | $7.02M | Buy |
289,803
+30,632
| +12% | +$714K | 0.46% | 50 |
|
|
2025
Q1 | $6.57M | Buy |
259,171
+290
| +0.1% | +$7.59K | 0.47% | 49 |
|
|
2024
Q4 | $6.87M | Sell |
258,881
-70,812
| -21% | -$1.92M | 0.47% | 44 |
|
|
2024
Q3 | $9.5M | Buy |
329,693
+54,490
| +20% | +$1.59M | 0.66% | 34 |
|
|
2024
Q2 | $7.7M | Buy |
275,203
+5,079
| +2% | +$140K | 0.58% | 37 |
|
|
2024
Q1 | $7.5M | Sell |
270,124
-18,891
| -7% | -$524K | 0.55% | 42 |
|
|
2023
Q4 | $8.32M | Buy |
289,015
+203,084
| +236% | +$6.14M | 0.68% | 35 |
|
|
2023
Q3 | $2.85M | Sell |
85,931
-6,792
| -7% | -$240K | 0.25% | 81 |
|
|
2023
Q2 | $3.4M | Sell |
92,723
-2,490
| -3% | -$96.9K | 0.3% | 73 |
|
|
2023
Q1 | $3.88M | Buy |
95,213
+2,583
| +3% | +$112K | 0.36% | 67 |
|
|
2022
Q4 | $4.75M | Sell |
92,630
-558
| -0.6% | -$26.8K | 0.44% | 54 |
|
|
2022
Q3 | $4.08M | Buy |
93,188
+75,415
| +424% | +$3.66M | 0.42% | 60 |
|
|
2022
Q2 | $932K | Sell |
17,773
-933
| -5% | -$47.5K | 0.13% | 85 |
|
|
2022
Q1 | $968K | Sell |
18,706
-830
| -4% | -$43.1K | 0.12% | 93 |
|
|
2021
Q4 | $1.15M | Sell |
19,536
-2,210
| -10% | -$109K | 0.14% | 88 |
|
|
2021
Q3 | $935K | Sell |
21,746
-1,030
| -5% | -$45.6K | 0.13% | 94 |
|
|
2021
Q2 | $892K | Buy |
22,776
+330
| +1% | +$12.8K | 0.13% | 96 |
|
|
2021
Q1 | $813K | Sell |
22,446
-153,514
| -87% | -$5.45M | 0.12% | 104 |
|
|
2020
Q4 | $6.48M | Buy |
175,960
+17,680
| +11% | +$649K | 1.02% | 26 |
|
|
2020
Q3 | $5.81M | Sell |
158,280
-3,936
| -2% | -$145K | 1.14% | 21 |
|
|
2020
Q2 | $5.3M | Buy |
162,216
+1,740
| +1% | +$62.3K | 1.09% | 23 |
|
|
2020
Q1 | $5.24M | Buy |
160,476
+36,073
| +29% | +$1.3M | 1.32% | 18 |
|
|
2019
Q4 | $4.87M | Buy |
124,403
+10,862
| +10% | +$408K | 0.9% | 27 |
|
|
2019
Q3 | $4.08M | Buy |
113,541
+6,118
| +6% | +$234K | 0.38% | 47 |
|
|
2019
Q2 | $4.65M | Buy |
107,423
+6,926
| +7% | +$290K | 0.45% | 38 |
|
|
2019
Q1 | $4.27M | Buy |
100,497
+2,116
| +2% | +$89.3K | 0.43% | 36 |
|
|
2018
Q4 | $4.3M | Buy |
98,381
+8,346
| +9% | +$365K | 0.51% | 28 |
|
|
2018
Q3 | $3.97M | Buy |
90,035
+1,645
| +2% | +$66.7K | 0.37% | 36 |
|
|
2018
Q2 | $3.21M | Buy |
88,390
+1,544
| +2% | +$55.6K | 0.29% | 51 |
|
|
2018
Q1 | $3.08M | Buy |
86,846
+2,202
| +3% | +$79.8K | 0.3% | 51 |
|
|
2017
Q4 | $3.07M | Buy |
84,644
+181
| +0.2% | +$6.5K | 0.29% | 48 |
|
|
2017
Q3 | $3.02M | Buy |
84,463
+1,883
| +2% | +$63.8K | 0.3% | 49 |
|
|
2017
Q2 | $2.77M | Buy |
82,580
+1,642
| +2% | +$54.6K | 0.28% | 52 |
|
|
2017
Q1 | $2.77M | Buy |
80,938
+765
| +1% | +$25.4K | 0.29% | 49 |
|
|
2016
Q4 | $2.6M | Buy |
80,173
+6,049
| +8% | +$195K | 0.29% | 50 |
|
|
2016
Q3 | $2.51M | Buy |
74,124
+2,645
| +4% | +$93.2K | 0.27% | 49 |
|
|
2016
Q2 | $2.52M | Buy |
71,479
+1,468
| +2% | +$49.4K | 0.28% | 49 |
|
|
2016
Q1 | $2.08M | Buy |
70,011
+53,745
| +330% | +$1.62M | 0.25% | 58 |
|
|
2015
Q4 | $525K | Sell |
16,266
-3,377
| -17% | -$112K | 0.06% | 129 |
|
|
2015
Q3 | $617K | Buy |
19,643
+1,815
| +10% | +$61.3K | 0.08% | 116 |
|
|
2015
Q2 | $597K | Buy |
17,828
+4,915
| +38% | +$169K | 0.07% | 122 |
|
|
2015
Q1 | $449K | Sell |
12,913
-168
| -1% | -$5.63K | 0.05% | 139 |
|
|
2014
Q4 | $408K | Sell |
13,081
-8,439
| -39% | -$255K | 0.04% | 154 |
|
|
2014
Q3 | $637K | Sell |
21,520
-654
| -3% | -$19.3K | 0.07% | 121 |
|
|
2014
Q2 | $658K | Buy |
22,174
+1,805
| +9% | +$54.2K | 0.07% | 121 |
|
|
2014
Q1 | $654K | Buy |
20,369
+7,326
| +56% | +$230K | 0.07% | 119 |
|
|
2013
Q4 | $399K | Buy |
13,043
+152
| +1% | +$4.66K | 0.04% | 161 |
|
|
2013
Q3 | $370K | Sell |
12,891
-720
| -5% | -$20.6K | 0.04% | 157 |
|
|
2013
Q2 | $381K | Hold |
13,611
| – | – | 0.05% | 153 |
|
Other funds holding PFE
Cadence Bank's PFE Position: Q4 2025 in Review
Cadence Bank reduced its Pfizer (PFE) stake by 9.6% in Q4 2025, selling an estimated $700K and leaving 261,420 shares worth $6.51M. The position accounts for 0.38% of the portfolio, ranked #58.
Cadence Bank first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $9.5M in Q3 2024. 2,932 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Cadence Bank held 261,420 shares of Pfizer worth $6.51M as of Q4 2025.
- Cadence Bank sold 27,740 Pfizer shares in Q4 2025, an estimated $700K.
- Pfizer made up 0.38% of Cadence Bank's portfolio in Q4 2025, its #58 holding.
- Cadence Bank first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- Cadence Bank's Pfizer position peaked at $9.5M in Q3 2024.
- 2,932 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Cadence Bank's 13F filing for Q4 2025, filed 30 Jan 2026.